Concepedia

Publication | Closed Access

The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study.

22

Citations

0

References

2020

Year

Abstract

PIVKA-II may be considered an independent predictor of macrovascular invasion from HCC cells and it can be used to better stratify HCC patients and should be evaluated in prospective studies for early detection of advanced HCC in metabolic subjects.